Neuronetics, Inc. STIM
At closeNov 4, 2026, 5:53 PM EST
After hours · Nov 4, 5:53 PM ET
- YTD
- +96.01%
- 1 year
- -5.75%
- Market cap
- 206.11M
- Revenue (ttm)
- 72.06M
- Profit margin
- -45.06%
- EPS (ttm)
- -0.43
- Shares out
- 65.00M
- Forward P/E
- -2.15
- YTD return
- +96.01%
- 1-year return
- -5.75%
- Volume
- 5.45M
- Avg volume
- 1.61M
- Open
- 2.77
- Previous close
- 2.26
- Day's range
- 2.55 – 3.05
- 52-week range
- 0.80 – 3.44
- Beta
- 2.22
- Analysts
- Buy
- Price target
- 2.67 (-1.4%)
- Earnings date
- Aug 12, 2024
1M +0.48 (+21.82%)
Key statistics
- Enterprise value
- 38.45M
- PEG ratio
- 0.00
- Price / sales
- 1.20
- Price / book
- 1.13
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -6.60%
- Free cash flow
- -15.35M
- Total cash
- 42.64M
- Total debt
- 62.62M
- Return on equity
- -100.13%
- Short % of float
- 2.59%
- 50-day average
- 1.02
- 200-day average
- 1.94
Analyst view
Consensus: buy
- Target (low)
- 2.00
- Target (mean)
- 2.67
- Target (high)
- 3.00
- Strong buy2
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 12, 2024
Expected Aug 12, 2024. Consensus EPS estimate -0.2425.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.23 | -0.29 | -0.06 | -26.09% |
| Aug 12, 2024 | Jun 1, 2024 | -0.27 | -0.33 | -0.06 | -22.22% |
| Aug 12, 2024 | Jun 1, 2024 | -0.27 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | -0.33 | -0.27 | +0.06 | +18.18% |
| May 7, 2024 | Mar 1, 2024 | -0.33 | — | — | — |
| Mar 5, 2024 | Dec 1, 2023 | -0.26 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 2024 | JMP Securities | main | Market Outperform | Market Outperform |
| Aug 13, 2024 | Canaccord Genuity | main | Buy | Buy |
| Aug 12, 2024 | William Blair | down | Outperform | Market Perform |
| May 14, 2024 | William Blair | up | Market Perform | Outperform |
| Mar 6, 2024 | Piper Sandler | reit | Overweight | Overweight |
| May 10, 2023 | JMP Securities | reit | — | Market Outperform |
About Neuronetics, Inc.
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- neurostar.com
News
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 
Neuronetics Q3 Earnings Call Highlights 
12 Health Care Stocks Moving In Wednesday's Intraday Session 
Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates 
Neuronetics Q3 2026 Earnings Call Transcript 
Neuronetics Q3 EPS $(0.02) Beats $(0.09) Estimate, Sales $41.962M Beat $40.425M Estimate 
Neuronetics Affirms FY2026 Sales Guidance of $160.000M-$164.000M vs $162.025M Est 
Neuronetics Reports Third Quarter 2026 Financial and Operating Results 
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call 
Neuronetics, Inc. (NASDAQ:STIM) Stock Now Rated “Moderate Buy” by Sell-Side Brokerages
Your note
Sign in to keep a note on STIM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAKEWELL JOHN K | Director | Stock Award(Grant) | May 24, 2023 | 114,352 |
| CAPPER JOSEPH H | Director | Stock Award(Grant) | May 24, 2023 | 43,147 |
| CASCELLA ROBERT A | Director | Purchase | Sep 11, 2024 | 453,098 |
| CONLEY SHERYL L | Director | Stock Award(Grant) | May 29, 2024 | 139,946 |
| FURLONG STEPHEN | Chief Financial Officer | Sale | Oct 7, 2024 | 497,408 |
| JAEGER WILFRED E | Director | Stock Award(Grant) | May 24, 2023 | 138,563 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Kent Lake PR LLC | 6.85% | 2,077,848 | 2.76M | Sep 29, 2024 |
| Cannell Capital LLC | 4.33% | 1,314,266 | 1.75M | Sep 29, 2024 |
| Vanguard Group Inc | 4.28% | 1,299,915 | 1.73M | Sep 29, 2024 |
| Masters Capital Management, LLC | 3.95% | 1,200,000 | 1.60M | Sep 29, 2024 |
| Balyasny Asset Management LLC | 3.77% | 1,144,232 | 1.52M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 1.92% | 581,800 | 773.79K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| First Eagle Small Opportunity Fund | 3.16% | 957,815 | 1.27M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.80% | 849,497 | 1.13M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.33% | 403,878 | 537.16K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.53% | 162,067 | 215.55K | Oct 30, 2024 |
| EQ Advisors Trust-1290 VT Gamco Small Company Value Port | 0.25% | 75,000 | 99.75K | Sep 29, 2024 |
| iShares Micro Cap ETF | 0.20% | 62,048 | 82.52K | Oct 30, 2024 |